Table 2 Clinical characteristics of 104 breast cancer patients in the TCIA-BRCA cohort
From: HLA-DQA1 expression is associated with prognosis and predictable with radiomics in breast cancer
Variables | Total (n = 104) | Training (n = 63) | Validation (n = 41) | p |
|---|---|---|---|---|
HLA-DQA1, n (%) | 1 | |||
Low | 50 (48) | 30 (48) | 20 (49) | |
High | 54 (52) | 33 (52) | 21 (51) | |
Age, n (%) | 0.251 | |||
~ 59 | 69 (66) | 45 (71) | 24 (59) | |
60~ | 35 (34) | 18 (29) | 17 (41) | |
PR_status, n (%) | 1 | |||
Negative | 25 (24) | 15 (24) | 10 (24) | |
Positive | 79 (76) | 48 (76) | 31 (76) | |
HER2_status, n (%) | 0.479 | |||
Equivocal/Indeterminate | 31 (30) | 19 (30) | 12 (29) | |
Negative | 58 (56) | 37 (59) | 21 (51) | |
Positive | 15 (14) | 7 (11) | 8 (20) | |
ER_status, n (%) | 0.232 | |||
Negative | 17 (16) | 13 (21) | 4 (10) | |
Positive | 87 (84) | 50 (79) | 37 (90) | |
Radiotherapy, n (%) | 0.15 | |||
No | 31 (30) | 15 (24) | 16 (39) | |
Yes | 73 (70) | 48 (76) | 25 (61) | |
Chemotherapy, n (%) | 0.6 | |||
No | 27 (26) | 18 (29) | 9 (22) | |
Yes | 77 (74) | 45 (71) | 32 (78) | |
T_stage, n (%) | 0.553 | |||
T1 | 40 (38) | 22 (35) | 18 (44) | |
T2 | 59 (57) | 37 (59) | 22 (54) | |
T3/T4 | 5 (5) | 4 (6) | 1 (2) | |
N_stage, n (%) | 0.519 | |||
N0 | 53 (51) | 30 (48) | 23 (56) | |
N1/N2/N3/NX | 51 (49) | 33 (52) | 18 (44) | |
M_stage, n (%) | 1 | |||
M0 | 96 (92) | 58 (92) | 38 (93) | |
M1/MX | 8 (8) | 5 (8) | 3 (7) | |
Histological_type, n (%) | 0.24 | |||
IDC | 89 (86) | 51 (81) | 38 (93) | |
ILC | 11 (11) | 9 (14) | 2 (5) | |
Other | 4 (4) | 3 (5) | 1 (2) | |
OS, n (%) | 1 | |||
Alive | 103 (99) | 62 (98) | 41 (100) | |
Dead | 1 (1) | 1 (2) | 0 (0) | |
OS.time, Median (Q1,Q3) | 0.727 | |||
40.53 (24.74, 64.03) | 40.1 (25.15, 64.23) | 40.97 (24.27, 60) | ||